MedPath

Fecal microbiota tRAnspLantation uSed TO improve postpraNdial bacterIAl translocation; the RALSTONIA study

Recruiting
Conditions
metabolic syndrome, diabetes mellitus
Registration Number
NL-OMON26108
Lead Sponsor
AMC-UvA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
24
Inclusion Criteria

• Male sex

• Caucasian

Exclusion Criteria

• A history of cardiovascular event (CVA, MI or pacemaker implantation)

• Use of any medication including PPI and antibiotics in the past three months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
changes in postprandial translocation of intestinal bacteria between donor and own ecal transplantation.<br>
Secondary Outcome Measures
NameTimeMethod
changes in (small) intestinal bacterial composition related to bacterial translocation. <br /><br>changes in visceral and subcutaneous adipose tissue and inflammatory tone between donor and own fecal transplantation
© Copyright 2025. All Rights Reserved by MedPath